By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

VioQuest Pharmaceuticals, Inc. 

1981 Pine Hall Drive

State College  Pennsylvania  16801  U.S.A.
Phone: 814-234-5054 Fax: 814-234-3161


SEARCH JOBS


Industry
Pharmaceutical






Company News
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Provides Strategic Alternatives Review, Announces Need for Capital and Potential Resignation of CEO, VP and CFO 10/27/2008 7:18:34 AM
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Receives 510(k) Response from FDA for Xyfid(TM) 9/10/2008 6:33:20 AM
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Announces Issuance of New U.S. Patent for Lenocta(TM) 8/26/2008 8:30:43 AM
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Announces Second Quarter 2008 Financial Results and Corporate Highlights 8/19/2008 11:03:57 PM
VioQuest Pharmaceuticals, Inc. (VQPH.OB)' VQD-002 Named One of 10 Most Promising Oncology Projects by Windhover Information Inc. 7/30/2008 9:05:23 AM
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Appoints Christopher P. Schnittker, CPA, as Chief Financial Officer 7/21/2008 10:10:41 AM
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Submits 510(k) Application to FDA for Xyfid(TM), a Novel Topical Agent for the Treatment of Various Skin Disorders 7/1/2008 10:14:58 AM
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Presents Phase 1 Data Showing Promising Immune Response and Safety Profile of Lenocta(TM) 6/2/2008 8:48:06 AM
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Announces Upcoming Lenocta(TM) Oral Presentation at the American Society of Clinical Oncology Annual Meeting 5/19/2008 12:43:37 PM
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Announces First Quarter 2008 Financial Results 5/15/2008 9:06:10 AM
12345678910
//-->